ArticleEuropean urology focus2021

Partial Response and Stable Disease Correlate with Positive Outcomes in Atezolizumab-treated Patients with Advanced Urinary Tract Carcinoma.

Jens Bedke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.